Alcon Inc. logo

Alcon Inc. (ALC)

Market Closed
3 Aug, 20:00
NYSE NYSE
$
70. 21
+1.27
+1.8422%
$
33.95B Market Cap
- P/E Ratio
1.22% Div Yield
1.78M Volume
- Eps
$ 68.94
Previous Close
Add Transaction
Day Range
69.54 70.89
Year Range
61.84 90.41
Want to track ALC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ALC closed today higher at $70.21, an increase of 1.8422% from yesterday's close, completing a monthly increase of 5.0262% or $3.36. Over the past 12 months, ALC stock lost -11.0139%.
ALC pays dividends to its shareholders, with the most recent payment made on May 07, 2026. The next estimated payment will be in In 9 months on May 07, 2027 for a total of $0.23203.
The last earnings report, released on May 19, 2026, missed the consensus estimates by -0.834%. On average, the company has fell short of earnings expectations by -0.5347%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ALC Chart

People also search for

CRM
Salesforce Inc
$ 185.95
+1.0488%
Uber Technologies, Inc.
$ 71.61
+1.7766%
Sony Group Corporation - Sponsored American Depositary Receipt
$ 22.63
-2.7085%
Capital One Financial Corporation
$ 15.46
+0.3245%
Capital One Financial Corporation
$ 18.14
+0.3874%
Here's Why Alcon (ALC) is a Strong Value Stock

Here's Why Alcon (ALC) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 10 hours ago
Do Options Traders Know Something About Alcon Stock We Don't?

Do Options Traders Know Something About Alcon Stock We Don't?

Investors need to pay close attention to ALC stock based on the movements in the options market lately.

Zacks | 4 days ago
Alcon (ALC) is a Top-Ranked Momentum Stock: Should You Buy?

Alcon (ALC) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 week ago

Alcon Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
DI
David Izzi Brown, LISLE/CUMMINGS Inc.
13 $1,301 $896.22 -$404.78 -31.11%
LC
Lisa Candera CIGNA INVESTMENTS Inc. /NEW
8,833 $551,771.02 $608,947.02 $57,176 10.36%
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
586 $47,895.84 $40,398.84 -$7,497 -15.65%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
96 $7,989.27 $6,618.24 -$1,371.03 -17.16%
CD
Carine Duboscq Groupama Asset Managment
112,208 $9.54M $7.74M -$1.8M -18.91%

Alcon Inc. Analysts

Name Quantity Cost Value Profit ($) Gain (%)
DS
David Saxon Needham
70.47 $4,609.2 $4,869.93 $260.73 5.66%
Jeff Johnson
Jeff Johnson Baird
249.4 $15,973.92 $17,236.11 $1,262.19 7.9%

Alcon Inc. (ALC) FAQ

What is the stock price today?

The current price is $70.21.

On which exchange is it traded?

Alcon Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is ALC.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.22%.

What is its market cap?

As of today, the market cap is 33.95B.

Has Alcon Inc. ever had a stock split?

No, there has never been a stock split.

Alcon Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
David J. Endicott CEO
NYSE Exchange
H01302103 CUSIP
CH Country
25,628 Employees
5 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

Alcon Inc. is a global leader in eye care, specializing in the research, development, manufacturing, distribution, and sales of a wide range of eye care products. Catering to both eye care professionals and patients, Alcon's mission is to enhance vision and improve people's lives through innovative products and solutions. The company's portfolio spans across surgical procedures and vision care, addressing a broad spectrum of eye health needs. Originally founded in 1945 as Alcon Universal S.A., the company underwent a name change to Alcon Inc. in December 2001 and has since established its headquarters in Geneva, Switzerland, marking its presence as a key player in the eye care industry on a global scale.

Products and Services

Alcon Inc.'s offerings are divided into two main segments: Surgical and Vision Care, each catering to distinct aspects of eye health and surgery.

  • Surgical Segment:
  • Within the surgical field, Alcon provides a comprehensive array of products including equipment, instrumentation, diagnostics, intraocular lenses (IOLs), and other implantables, along with various consumables. These specialized products support a wide range of procedures from cataract surgery to vitreoretinal operations. Notable products within this segment include the Centurion Vision System, LenSx Laser System for cataract treatment, Constellation Vision Systems for vitreoretinal surgeries, and the WaveLight Lasers for LASIK treatments. Additionally, Alcon offers innovative solutions like the NGENUITY 3D Visualization System and the ORA system for enhanced surgical precision and outcomes. Custom surgical packs and a variety of manual surgical instruments further complement Alcon’s surgical offerings.

  • Vision Care Segment:
  • Alcon’s Vision Care segment focuses on enhancing daily eye health and visual comfort through a wide range of products. This includes daily disposable, reusable, and color-enhancing contact lenses designed to meet diverse needs and preferences. Beyond corrective lenses, Alcon provides solutions for common eye concerns such as dry eye, ocular allergies, and glaucoma, as well as products for contact lens care. The segment is also home to ocular vitamins and redness relievers, aimed at maintaining overall eye health and comfort.

Contact Information

Address: Chemin de Blandonnet 8
Phone: 41 58 911 20 00